SCHEMBL6780767

SCHEMBL6780767

CCOc1ccccc1C(=O)N(Cc1cccnc1)Cc1ccccc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ KCNA5 P22460 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ THRB P10828 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ PDK1 Q15118 1/20 0.43
▸ TRPM8 Q7Z2W7 1/20 0.43
▸ GPBAR1 Q8TDU6 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ALKBH5 Q6P6C2 1/20 0.42
▸ TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6774110 0.91 SGMS2 (0.50) ALDH1A1KCNA5MAPTKMT2AHTT
SCHEMBL6777732 0.90 LPAR1 (0.52) ALDH1A1KCNA5MAPTKMT2AL3MBTL1
SCHEMBL6785255 0.85 LMNA (0.51) ALDH1A1MAPTKMT2AL3MBTL1HTT
SCHEMBL6781088 0.83 ALDH1A1 (0.45) ALDH1A1KCNA5MAPTL3MBTL1HTT
SCHEMBL6778426 0.83 KMT2A (0.48) ALDH1A1KCNA5MAPTKMT2AHTT
SCHEMBL6780567 0.82 GPBAR1 (0.49) ALDH1A1KCNA5MAPTKMT2AHTT
SCHEMBL6778233 0.79 HTT (0.51) ALDH1A1KCNA5MAPTKMT2AHTT
SCHEMBL6778429 0.78 MAPT (0.50) ALDH1A1MAPTL3MBTL1LMNAPDK1
SCHEMBL7673590 0.77 ALDH1A1 (0.46) ALDH1A1KCNA5MAPTKMT2AL3MBTL1
SCHEMBL6783823 0.76 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT ALDH1A1 646/4885KCNA5 3796/4885MAPT 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback